PharVision Advisers’s Brandywine Realty Trust BDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$43K Sell
15,878
-50,647
-76% -$152K 0.44% 93
2025
Q4
$194K Sell
66,525
-32,830
-33% -$112K 0.1% 569
2025
Q3
$414K Buy
+99,355
New +$418K 0.23% 72

Other funds holding BDN

PharVision Advisers's BDN Position: Q1 2026 in Review

PharVision Advisers reduced its Brandywine Realty Trust (BDN) stake by 76% in Q1 2026, selling an estimated $152K and leaving 15,878 shares worth $43K. The position accounts for 0.44% of the portfolio, ranked #93.

PharVision Advisers first reported a position in BDN in Q3 2025 and has held it in 3 quarters since. The position peaked at $414K in Q3 2025. 230 funds tracked by Wall St. Rank hold BDN as of Q1 2026.

  • PharVision Advisers held 15,878 shares of Brandywine Realty Trust worth $43K as of Q1 2026.
  • PharVision Advisers sold 50,647 Brandywine Realty Trust shares in Q1 2026, an estimated $152K.
  • Brandywine Realty Trust made up 0.44% of PharVision Advisers's portfolio in Q1 2026, its #93 holding.
  • PharVision Advisers first reported a position in Brandywine Realty Trust in Q3 2025 and has held it in 3 quarters since.
  • PharVision Advisers's Brandywine Realty Trust position peaked at $414K in Q3 2025.
  • 230 funds tracked by Wall St. Rank held Brandywine Realty Trust as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.